Sign in

France welcomes Recipharm and Moderna agreement over Covid vaccine

The head of the European Commission said on Tuesday that the European Union has struck a deal for up to 160 million doses of Moderna’s Covid-19 vaccine candidate, taking the EU’s potential stock of Covid-19 doses to nearly 2 billion.

Published on: Nov 25, 2020, 14:25:49 IST
Paris | By
Share
Share via
  • facebook
  • twitter
  • linkedin
  • whatsapp
Copy link
  • copy link

French Industry Minister Agnes Pannier-Runacher said on Wednesday that Sweden-based pharmaceutical company Recipharm has signed a letter of intent with US firm Moderna to produce some of its Covid-19 vaccine candidate in France.

Sweden-based pharmaceutical company Recipharm has signed a letter of intent with US firm Moderna to produce some of its Covid-19 vaccine candidate in France (via Reuters)
Sweden-based pharmaceutical company Recipharm has signed a letter of intent with US firm Moderna to produce some of its Covid-19 vaccine candidate in France (via Reuters)

Pannier-Runacher said that Recipharm has four plants in France.

The head of the European Commission said on Tuesday that the European Union has struck a deal for up to 160 million doses of Moderna’s Covid-19 vaccine candidate, taking the EU’s potential stock of Covid-19 doses to nearly 2 billion.

Stay updated with the latest Business News, stock market updates, petrol and diesel prices, gold and silver rates, income tax updates and major developments from India and across the world.